Yanfang MIAO, Yuxian WANG. Traditional Chinese medicine research progress of diarrhea predominant irritable bowel syndrome (liver depression and spleen deficiency syndrome). [J]. Shanghai Journal of Traditional Chinese Medicine 55(7):91-94(2021)
DOI:
Yanfang MIAO, Yuxian WANG. Traditional Chinese medicine research progress of diarrhea predominant irritable bowel syndrome (liver depression and spleen deficiency syndrome). [J]. Shanghai Journal of Traditional Chinese Medicine 55(7):91-94(2021) DOI: 10.16305/j.1007-1334.2021.2008055.
Traditional Chinese medicine research progress of diarrhea predominant irritable bowel syndrome (liver depression and spleen deficiency syndrome)
Diarrhea predominant irritable bowel syndrome (IBS-D) is a common intestinal dysfunction disease in clinic. Traditional Chinese medicine (TCM) pathogenesis may vary in different cases, for instance, liver-spleen imbalance, liver hyperactivity and spleen deficiency and liver depression and spleen deficiency, but it is the liver and spleen that are always affected and the most common syndrome is liver depression and spleen deficiency. The TCM research progress of IBS-D (liver depression and spleen deficiency syndrome) was reviewed from three aspects: etiology and pathogenesis, clinical research and mechanism of action. TCM prescription with the effect of regulating liver and spleen, represented by Tongxie Yaofang, can improve symptoms of abdominal pain and diarrhea, psychological and behavioral state of patients with IBS-D of liver depression and spleen deficiency syndrome, and then improve their quality of life. When it comes to the mechanism of action, the therapeutic effects of TCM can be realized by regulating brain-gut axis, visceral hypersensitivity and related ion transport.
CHEY W D, KURLANDER J, ESWARAN S. Irritable bowel syndrome: a clinical review[J]. JAMA, 2015, 313(9): 949-958.
李梅. 肠易激综合征中医证候临床流行病学调查研究[D]. 广州:广州中医药大学,2012.
ZHU J J, LIU S, SU X L, et al. Efficacy of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A meta-analysis of randomized, double-blind, placebo-controlled trials[J/OL]. Evid Based Complement Alternat Med, 2016, 2016: 4071260[2020-07-30]. https://pubmed.ncbi.nlm.nih.gov/27547226/https://pubmed.ncbi.nlm.nih.gov/27547226/.
YIN Y, ZHONG L, WANG J W, et al. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P[J]. World J Gastroenterol, 2015, 21(15): 4536-4546.
LI J,CUI H,CAI Y,et al. Tong-Xie-Yao-Fang Regulates 5-HT level in diarrhea predominant irritable bowel syndrome through gut microbiota modulation[J]. Front Pharmacol, 2018(9): 1110.
MAO Q, SHI L, WANG Z G, et al. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome[J/OL]. J Ethnopharmacol, 2017, 201: 123-135[2020-07-30]. https://pubmed.ncbi.nlm.nih.gov/27547226/https://pubmed.ncbi.nlm.nih.gov/27547226/.
CHAO G, WANG Y, YE F, et al. Regulation of colonic mucosal microRNA expression via multiple targets in visceral hypersensitivity rats by Tongxieyaofang[J]. Yonsei Med J, 2018, 59(8): 945-950.
LU X F, ZHANG S S, YANG C,et al. Effect of TongXie-YaoFang on Cl(-) and HCO3 (-) transport in diarrhea-predominant irritable bowel syndrome rats[J/OL]. Evid Based Complement Alternat Med, 2016, 2016: 7954982[2020-07-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923577/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923577/.